| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xencor, Inc. (XNCR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. XNCR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 477.3K | $6.66M | - | |
| VP | 242.9K | $3.39M | - | |
| Dir | 110.4K | $1.54M | - | |
| CFO | 75.9K | $1.06M | - | |
| Dir | 15.5K | $217.0K | -5,064 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | Kuch John J68 | Sr. Vice President &CFO | Sell | 849 | $23.50 | $19,953.03 | -0.7% | -5.4% | -41.9% | |
| Mar 11, 2024 | Eckert Celia71 | SVP, General Counsel | Sell | 850 | $23.50 | $19,976.53 | -1.8% | -5.4% | -41.9% | |
| Mar 11, 2024 | Desjarlais John R76 | Sr. Vice President &CSO | Sell | 1,280 | $23.50 | $30,082.30 | -0.7% | -5.4% | -41.9% | |
| Mar 11, 2024 | Dahiyat Bassil I74 | President &CEO | Sell | 2,741 | $23.50 | $64,418.43 | -0.8% | -5.4% | -41.9% | |
| Mar 6, 2024 | Gustafson Kurt A81 | Director | Sale+OE | 14,000 | $23.18 | $324,452.80 | -70.0% | -1.4% | -41.9% | |
| Mar 5, 2024 | Kuch John J68 | Sr. Vice President &CFO | Sell | 4,474 | $23.43 | $104,821.35 | -3.5% | +4.9% | -39.2% | |
| Mar 5, 2024 | Desjarlais John R76 | Sr. Vice President &CSO | Sell | 6,629 | $23.43 | $155,310.84 | -3.8% | +4.9% | -39.2% | |
| Mar 5, 2024 | Eckert Celia71 | SVP, General Counsel | Sell | 3,892 | $23.43 | $91,185.67 | -10.5% | +4.9% | -39.2% | |
| Mar 5, 2024 | Dahiyat Bassil I74 | President &CEO | Sell | 12,528 | $23.43 | $293,518.51 | -4.0% | +4.9% | -39.2% | |
| Feb 13, 2024 | Desjarlais John R76 | Sr. Vice President &CSO | Sale+OE | 54,108 | $19.38 | $1,048,742.90 | -25.1% | +11.6% | -15.2% |